Afya Ltd
NASDAQ:AFYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Afya Ltd
Cash & Cash Equivalents
Afya Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Afya Ltd
NASDAQ:AFYA
|
Cash & Cash Equivalents
R$1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
V
|
Vasta Platform Ltd
NASDAQ:VSTA
|
Cash & Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cogna Educacao SA
BOVESPA:COGN3
|
Cash & Cash Equivalents
R$78.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
32%
|
CAGR 10-Years
17%
|
|
|
YDUQS Participacoes SA
BOVESPA:YDUQ3
|
Cash & Cash Equivalents
R$982.3m
|
CAGR 3-Years
35%
|
CAGR 5-Years
37%
|
CAGR 10-Years
35%
|
|
|
Cruzeiro do Sul Educacional SA
BOVESPA:CSED3
|
Cash & Cash Equivalents
R$808.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Vitru Brasil Empreendimentos Participacoes e Comercio SA
BOVESPA:VTRU3
|
Cash & Cash Equivalents
R$21.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Afya Ltd
Glance View
Afya Ltd. is an intriguing player in the education and healthcare sectors of Brazil, carving its niche in the market by providing educational services to medical students and professionals. Founded in 2017, the company's journey began with a mission to tackle the chronic shortage of qualified healthcare professionals in the country. Through a series of strategic acquisitions, Afya rapidly expanded its portfolio of medical schools and associated educational programs, becoming the preeminent provider of medical courses in Brazil. The company's growth is anchored in its distinctive hybrid business model that blends traditional brick-and-mortar educational institutions with a dynamic digital learning platform, thereby ensuring comprehensive learning experiences for aspiring medical professionals. Revenue generation for Afya rests on its ability to enroll students into its extensive array of undergraduate and graduate medical programs, as well as continuing education courses that are mandated for medical professionals in Brazil. By leveraging economies of scale, Afya manages to run these programs efficiently, resulting in robust financial performance. The company makes money primarily through tuition fees, which are supplemented by its digital offerings, catering to a broader array of healthcare education needs. Through its digital platform, Afya not only enhances accessibility to its educational content but also taps into the growing demand for online learning solutions. This dual-channel approach enables Afya to remain agile in a rapidly evolving educational landscape while reinforcing its commitment to improving Brazil's healthcare by shaping the next generation of medical professionals.
See Also
What is Afya Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.1B
BRL
Based on the financial report for Dec 31, 2025, Afya Ltd's Cash & Cash Equivalents amounts to 1.1B BRL.
What is Afya Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
1%
Over the last year, the Cash & Cash Equivalents growth was 24%. The average annual Cash & Cash Equivalents growth rates for Afya Ltd have been 1% over the past three years , 1% over the past five years .